Response
We thank Dr Kahn for his pertinent question about our study. We have accordingly reanalyzed our cross-sectional data obtained on the same 1317 elderly women to estimate the distinct influences of peripheral fat mass as measured by dual-energy x-ray absorptiometry in the lower limbs compared with that in the upper limbs.
We found a stronger inverse association of the severity score for aortic calcification with fat mass in the lower (rϭϪ0.142, Pϭ0.001) compared with fat mass in the upper limbs (rϭϪ0.062, Pϭ0.023). After adjusting for all potential cardiovascular confounders, the independent inverse correlation with fat mass in the lower limbs remained virtually unchanged (rϭϪ0.130, PϽ0.001), whereas the correlation with fat mass in the upper limbs no longer was statistically significant (rϭϪ0.042, Pϭ0.129).
Similar lower-limb versus upper-limb contrasts were found when we examined the correlations with metabolic risk factors independent of age, body mass index, central fat mass, level of education, coffee and alcohol consumption, weekly fitness activity, current and previous smoking, diabetes, and current use of hormone replacement therapy. Under these conditions, the lower-limb and upper-limb partial correlations for fasting glucose were Ϫ0.137 (PϽ0.001) and Ϫ0.023 (Pϭ0.422), the correlations for white blood cell count were Ϫ0.082 (Pϭ0.004) and Ϫ0.030 (Pϭ0.281), and those for total cholesterol were Ϫ0.079 (Pϭ0.005) and Ϫ0.052 (Pϭ0.067). Both compartments appeared to exhibit a favorable effect on serum triglyceride (rϭϪ0.239 [PϽ0.001] and rϭϪ0.112 [PϽ0.001], respectively).
In the subpopulation of 290 women with a more thorough analysis of metabolic risk profile, the lower-limb and upper-limb partial correlations for the homeostasis assessment of insulin resistance index were Ϫ0.140 (Pϭ0.023) and 0.048 (Pϭ0.437), the correlations for HDL cholesterol were 0.176 (Pϭ0.004) and 0.105 (Pϭ0.087), and those for lipoprotein (a) were Ϫ0.146 (Pϭ0.017) and Ϫ0.056 (Pϭ0.366). None of the compartments was associated with apolipoprotein A1 or LDL cholesterol, whereas both compartments were significantly associated with apolipoprotein B (rϭϪ0.261 [PϽ0.001] and rϭϪ0.144 [Pϭ0.019], respectively).
These results confirm Dr Kahn's implication that the antidiabetic and antiatherogenic influence of peripheral fat mass is attributable primarily to fat mass on the lower limbs. Our findings suggest a need for thorough assessment of the diagnostic and prognostic value of simple anthropometric measures of lower-body fat depots. Studies to clarify the determinants of lower-body fat mass might also contribute to the prevention of cardiovascular disease.
